rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Zura Bio Limited - Class A

ZURA · Nasdaq

Health CareBiotechnologyNot moving yet

ZURA stood above a rising 150-day average in 36 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 23.1% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 6
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$25.0M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
95 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 36 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$24.0MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months0
Buyers · sellers2 · 0
WhoDidSharesTraded
Ai Biotechnology Llc10% ownerbought2,000,000at $6.2526 Feb 2026filed 2 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders95+4 on the quarter
New · exited28 · 24
Reported value$429.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
MONTANOVA CAPITAL, LLCadded · filed 14 Aug 20269,443,001$55.7M+376,000+4.1%
Venrock Adviser, LLCunchanged · filed 14 Aug 20266,434,990$38.0M00.0%
MPM BIOIMPACT LLCnew · filed 14 Aug 20264,472,843$26.4M+4,472,843
JPMORGAN CHASE & COnew · filed 12 Aug 20264,354,715$24.5M+4,354,715
GREAT POINT PARTNERS LLCunchanged · filed 14 Aug 20264,215,930$24.9M00.0%
BRAIDWELL LPreduced · filed 14 Aug 20263,980,295$23.5M-8,694−0.2%
Siren, L.L.C.unchanged · filed 13 Aug 20263,734,866$22.0M00.0%
BlackRock, Inc.added · filed 7 Aug 20263,614,695$21.3M+3,157,336+690.3%
Commodore Capital LPunchanged · filed 14 Aug 20263,250,000$19.2M00.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.unchanged · filed 14 Aug 20262,750,000$16.2M00.0%
31 Mar 2023 – 30 Jun 2026
44892Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Ajay Nirula Company insiderDirector · last 17 Jun 20260 · 0
Amit Munshi Company insiderDirector · last 17 Jun 20262 · 0
Daniel J. Becker Company insiderDirector · last 17 Jun 20260 · 0
Jennifer Jarrett Company insiderDirector · last 17 Jun 20260 · 0
Mark Eisner Company insiderDirector · last 17 Jun 20260 · 0
Parvinder Thiara Company insiderDirector · last 17 Jun 20260 · 3
Steven J. Schoch Company insiderDirector · last 17 Jun 20260 · 0
Eric J. Hyllengren Company insiderChief Financial Officer · last 1 Apr 20260 · 0
Gary Whale Company insiderChief Technology Officer · last 1 Apr 20260 · 0
Kim Davis Company insiderChief Legal Officer · last 1 Apr 20260 · 0
Kiran Nistala Company insiderOfficer · last 1 Apr 20261 · 0
Sandeep Chidambar Kulkarni Company insiderChief Executive Officer · last 1 Apr 20260 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-74.1%
Share count trendFY 2025 · to 16 Mar 202628.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$109.4M
Free cash flowFY 2025 · to 31 Dec 2025−$64.9M

Analyst forecasts

No analyst forecasts yet.